Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC1 | P19801 | 6/20 | 0.57 |
| ▸ | AOC3 | Q16853 | 6/20 | 0.57 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.55 |
| ▸ | CHUK | O15111 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CASP7 | P55210 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30448578 | 1.00 | AOC1 (0.57) | AOC1AOC3KDM4CCHUKCA12 | |
| SCHEMBL1630931 | 0.80 | — | — | |
| SCHEMBL827896 | 0.80 | — | — | |
| SCHEMBL3953493 | 0.80 | PTGS1 (0.59) | AOC1AOC3KDM4CPTGS1PTGS2 | |
| SCHEMBL23460857 | 0.78 | — | — | |
| SCHEMBL10141340 | 0.78 | — | — | |
| SCHEMBL2492621 | 0.78 | — | — | |
| SCHEMBL10141336 | 0.78 | — | — | |
| SCHEMBL18986531 | 0.78 | — | — | |
| SCHEMBL10141341 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954709-A | Preparation method of sulfoxide compound, aniline compound and preparation method of aniline compound | 帕潘纳(北京)科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-117942277-B | Skin anti-wrinkle and repairing composition and preparation method thereof | 广州联颖化妆品有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-118320125-A | Supermolecule self-assembled nano diagnosis and treatment agent based on fluorinated cyclodextrin and porphyrin, and preparation method and application thereof | 中山大学 | 2024-07-12 | — | — | CN | claimed |
| CN-117756996-A | Rust-resistant polycarboxylate superplasticizer for ultra-high-performance concrete and preparation method thereof | 中交二航武汉港湾新材料有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116693590-A | Fusidic acid derivative and preparation method and application thereof | 南京工业大学 | 2023-09-05 | — | — | CN | claimed |
| CN-115322126-B | Polyaromatic hydrocarbon compound and preparation method and application thereof | 九江学院 | 2023-04-28 | — | — | CN | claimed |
| CN-115960115-A | Fluorescein derivative and preparation method and application thereof | 石河子大学 | 2023-04-14 | — | — | CN | claimed |
| CN-115322126-A | Polyaromatic hydrocarbon compound and preparation method and application thereof | 九江学院 | 2022-11-11 | — | — | CN | claimed |
| CN-113248831-A | Efficient PP flame-retardant master batch and preparation method thereof | 苏州羽凡工程塑料有限公司 | 2021-08-13 | — | — | CN | claimed |
| US-11046663-B2 | Entecavir intermediate, synthetic method thereof and synthetic method for entecavir | LAUNCH-PHARMA TECHNOLOGIES, LTD. (CN) | 2021-06-29 | — | — | US | claimed |
| CN-111039945-B | Purification method for protecting meropenem | 山东安弘制药有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-109705063-B | Entecavir intermediate and synthetic method thereof, and synthetic method of entecavir | 广州市朗启医药科技有限责任公司 | 2021-01-01 | — | — | CN | claimed |
| CN-111825738-A | Betulin derivative and hydrophilic modification product thereof, nano solution and preparation method thereof | 中检科医药科技(北京)集团有限公司 | 2020-10-27 | — | — | CN | claimed |
| CN-109503337-B | Triptycene oxygen-containing straight-chain diol functional material, preparation and application thereof | 北京理工大学 | 2020-09-25 | — | — | CN | claimed |
| US-20200255390-A1 | ENTECAVIR INTERMEDIATE, SYNTHETIC METHOD THEREOF AND SYNTHETIC METHOD FOR ENTECAVIR | LAUNCH-PHARMA TECHNOLOGIES, LTD. (CN) | 2020-08-13 | — | — | US | claimed |
| CN-111039945-A | Purification method for protecting meropenem | 山东安弘制药有限公司 | 2020-04-21 | — | — | CN | claimed |
| CN-109705063-A | The synthetic method of entecavir midbodies and its synthetic method and Entecavir | 广州市朗启医药科技有限责任公司 | 2019-05-03 | — | — | CN | claimed |
| CN-105504293-B | A kind of preparation and application of fluorescence star block copolymer | 北京化工大学 | 2019-03-01 | — | — | CN | claimed |
| CN-102311454-B | Compound lipid containing porphyrin ring functional groups, preparation method and application thereof | HARBIN INST OF TECHNOLOGY | 2014-06-04 | — | — | CN | claimed |
| CN-122055058-A | Biaryl compound and method for controlling plant disease | 住友化学株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-119954709-A | Preparation method of sulfoxide compound, aniline compound and preparation method of aniline compound | 帕潘纳(北京)科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-12260969-B2 | Conductive film, method for producing same, conductor, resist pattern formation method, and laminate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-03-25 | — | — | US | disclosed |
| CN-116693590-B | Fusidic acid derivative and preparation method and application thereof | 南京工业大学 | 2025-03-18 | — | — | CN | disclosed |
| CN-119139560-A | Injectable hydrogel with anti-inflammatory and drainage functions and capable of promoting anal fistula to heal and preparation method thereof | 中山大学附属第五医院 | 2024-12-17 | — | — | CN | disclosed |
| US-20240301264-A1 | Thermally Conductive Electrically Resistive Low Density Adhesive | ZEPHYROS, INC. | 2024-09-12 | — | — | US | disclosed |
| CN-118320125-A | Supermolecule self-assembled nano diagnosis and treatment agent based on fluorinated cyclodextrin and porphyrin, and preparation method and application thereof | 中山大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-118164952-A | Preparation method of masmipide | 山东新时代药业有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-115262031-B | Fluorescent chitin nanofiber and preparation method and application thereof | 南京林业大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-117756996-A | Rust-resistant polycarboxylate superplasticizer for ultra-high-performance concrete and preparation method thereof | 中交二航武汉港湾新材料有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117402200-A | Perylene derivative and preparation method and application thereof | 西北师范大学 | 2024-01-16 | — | — | CN | disclosed |
| EP-4264731-A1 | THERMALLY CONDUCTIVE ELECTRICALLY RESISTIVE LOW DENSITY ADHESIVE | Zephyros Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| CN-116848703-A | Heat conductive resistive low density adhesive | 泽费罗斯股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116693590-A | Fusidic acid derivative and preparation method and application thereof | 南京工业大学 | 2023-09-05 | — | — | CN | disclosed |
| CN-115960115-A | Fluorescein derivative and preparation method and application thereof | 石河子大学 | 2023-04-14 | — | — | CN | disclosed |
| CN-111825738-B | Betulin derivative and hydrophilic modification product thereof, nano solution and preparation method thereof | 中检科医药科技(北京)集团有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-112881680-B | Method for preparing dsDNA-linked magnetic particles | 深圳市卓润生物科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| CN-115262031-A | Fluorescent chitin nano-fiber and preparation method and application thereof | 南京林业大学 | 2022-11-01 | — | — | CN | disclosed |
| CN-113123124-B | High-temperature-resistant carbon fiber sizing agent containing alkylated graphene, and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2022-10-14 | — | — | CN | disclosed |
| CN-114933582-A | Based on pair H 2 O 2 Responsive tea extract EGCG prodrug and preparation method and application thereof | 江苏下蜀黄土农业科技有限公司 | 2022-08-23 | — | — | CN | disclosed |
| WO-2022129299-A1 | THERMALLY CONDUCTIVE ELECTRICALLY RESISTIVE LOW DENSITY ADHESIVE | ZEPHYROS, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| CN-111819637-B | Conductive film and method for producing same, conductive body, method for forming resist pattern, and laminate | 三菱化学株式会社 | 2022-05-31 | — | — | CN | disclosed |
| US-20220151985-A1 | IMMUNOSTIMULATOR AND FOOD OR BEVERAGE FOR IMMUNOSTIMULATION | Amino Up Co., Ltd. (JP) | 2022-05-19 | — | — | US | disclosed |
| EP-3950066-A1 | IMMUNOSTIMULATOR AND FOOD OR BEVERAGE FOR IMMUNOSTIMULATION | Amino Up Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-113710325-A | Immunostimulant and food and drink for immunostimulation | 阿明诺株式会社 | 2021-11-26 | — | — | CN | disclosed |
| CN-113248831-A | Efficient PP flame-retardant master batch and preparation method thereof | 苏州羽凡工程塑料有限公司 | 2021-08-13 | — | — | CN | disclosed |
| US-11046663-B2 | Entecavir intermediate, synthetic method thereof and synthetic method for entecavir | LAUNCH-PHARMA TECHNOLOGIES, LTD. (CN) | 2021-06-29 | — | — | US | disclosed |
| CN-112881680-A | Method for preparing dsDNA-linked magnetic particles | 深圳市卓润生物科技有限公司 | 2021-06-01 | — | — | CN | disclosed |
| CN-111039945-B | Purification method for protecting meropenem | 山东安弘制药有限公司 | 2021-04-20 | — | — | CN | disclosed |
| EP-3144351-B1 | CONDUCTIVE COMPOSITION, ANTISTATIC FILM, LAMINATE AND PRODUCTION THEREFOR, AND PRODUCTION METHOD FOR PHOTOMASK | MITSUBISHI CHEM CORP (JP) | 2021-03-31 | — | — | EP | disclosed |
| EP-3767639-A1 | CONDUCTIVE FILM, METHOD FOR PRODUCING SAME, CONDUCTOR, RESIST PATTERN FORMATION METHOD, AND LAMINATE | Mitsubishi Chemical Corporation (JP) | 2021-01-20 | — | — | EP | disclosed |
| US-20210005343-A1 | CONDUCTIVE FILM, METHOD FOR PRODUCING SAME, CONDUCTOR, RESIST PATTERN FORMATION METHOD, AND LAMINATE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-01-07 | — | — | US | disclosed |
| CN-109705063-B | Entecavir intermediate and synthetic method thereof, and synthetic method of entecavir | 广州市朗启医药科技有限责任公司 | 2021-01-01 | — | — | CN | disclosed |
| CN-112028583-A | Anti-permeability wear-resistant concrete and preparation method thereof | 浙江拓邦混凝土有限公司 | 2020-12-04 | — | — | CN | disclosed |
| CN-106661335-B | Conductive composition, antistatic film, laminate, method for producing same, and method for producing photomask | 三菱化学株式会社 | 2020-11-27 | — | — | CN | disclosed |
| CN-111825738-A | Betulin derivative and hydrophilic modification product thereof, nano solution and preparation method thereof | 中检科医药科技(北京)集团有限公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-111819637-A | Conductive film and method for producing same, conductive body, method for forming resist pattern, and laminate | 三菱化学株式会社 | 2020-10-23 | — | — | CN | disclosed |
| WO-2020203593-A1 | IMMUNOSTIMULATOR AND FOOD OR BEVERAGE FOR IMMUNOSTIMULATION | 株式会社アミノアップ | 2020-10-08 | — | — | WO | disclosed |
| US-20200255390-A1 | ENTECAVIR INTERMEDIATE, SYNTHETIC METHOD THEREOF AND SYNTHETIC METHOD FOR ENTECAVIR | LAUNCH-PHARMA TECHNOLOGIES, LTD. (CN) | 2020-08-13 | — | — | US | disclosed |
| CN-111039945-A | Purification method for protecting meropenem | 山东安弘制药有限公司 | 2020-04-21 | — | — | CN | disclosed |
| CN-107337748-B | A kind of styrene copolymer and preparation method thereof with reversible crosslink key | 四川大学 | 2019-11-26 | — | — | CN | disclosed |
| CN-108251104-B | A kind of substituted indole -2- carboxylic acids Bcl-2 small-molecule fluorescent probe and its application | 山东大学 | 2019-11-05 | — | — | CN | disclosed |
| WO-2019177096-A1 | CONDUCTIVE FILM, METHOD FOR PRODUCING SAME, CONDUCTOR, RESIST PATTERN FORMATION METHOD, AND LAMINATE | 三菱ケミカル株式会社 | 2019-09-19 | — | — | WO | disclosed |
| CN-107628999-B | The preparation method of Aripiprazole dodecylate | 苏州华健瑞达医药技术有限公司 | 2019-07-02 | — | — | CN | disclosed |
| CN-106680257-B | β -galactosidase fluorescence sensor based on silicon nanowires and preparation method and application thereof | 中国科学院理化技术研究所 | 2019-05-14 | — | — | CN | disclosed |
| CN-109705063-A | The synthetic method of entecavir midbodies and its synthetic method and Entecavir | 广州市朗启医药科技有限责任公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-105504293-B | A kind of preparation and application of fluorescence star block copolymer | 北京化工大学 | 2019-03-01 | — | — | CN | disclosed |
| CN-108251104-A | A kind of substituted indole -2- carboxylic acids Bcl-2 small-molecule fluorescent probes and its application | 山东大学 | 2018-07-06 | — | — | CN | disclosed |
| US-20170261854-A1 | CONDUCTIVE COMPOSITION, ANTISTATIC FILM, LAMINATE AND PRODUCTION THEREFOR, AND PRODUCTION METHOD FOR PHOTOMASK | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-09-14 | — | — | US | disclosed |
| US-20170137468-A1 | MODULATION OF COMPLEMENT ACTIVITY | UCB HOLDINGS, INC. | 2017-05-18 | — | — | US | disclosed |
| EP-3144351-A1 | CONDUCTIVE COMPOSITION, ANTISTATIC FILM, LAMINATE AND PRODUCTION THEREFOR, AND PRODUCTION METHOD FOR PHOTOMASK | Mitsubishi Rayon Co., Ltd. (JP) | 2017-03-22 | — | — | EP | disclosed |
| CN-105968523-A | Nano reinforcing antioxidant geogrid and preparation method thereof | 安徽杰奥玛克合成材料科技有限公司 | 2016-09-28 | — | — | CN | disclosed |
| EP-2474551-B1 | Organic semiconductor compound, and transistor and electronic device including the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2014-01-01 | — | — | EP | disclosed |
| US-7872059-B2 | Polyurethanes, acryl resins, and metal (cobalt, nickel, palladium, and/or ruthenium); engravable flexographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-7872059-B2 | Polyurethanes, acryl resins, and metal (cobalt, nickel, palladium, and/or ruthenium); engravable flexographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20100266539-A1 | CHEMOKINE RECEPTOR ANTAGONIST AND MEDICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-7732442-B2 | Chemokine receptor antagonist and medical use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-06-08 | — | — | US | disclosed |
| WO-2008154023-A1 | NOVEL USES OF PPAR DELTA AGONISTS | CERENIS THERAPEUTICS S.A. (FR) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008136815-A2 | 5, 6-RING ANNULATED INDOLE DERIVATIVES AND USE THEREOF | SCHERING CORPORATION (US) | 2008-11-13 | — | — | WO | disclosed |
| US-20080194762-A1 | Polyurethanes, acryl resins, and metal (cobalt, nickel, palladium, and/or ruthenium); engravable flexographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20070254886-A1 | Chemokine Receptor Antagonist and Medical Use Thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-11-01 | — | — | US | disclosed |
| CN-1744903-A | Process for the preparation of 2' -branched nucleosides | IDENIX CAYMAN LTD (KY) | 2006-03-08 | — | — | CN | disclosed |
| US-6867281-B2 | Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2005-03-15 | — | — | US | disclosed |
| WO-2005020293-A2 | HIGHLY CONDUCTING AND TRANSPARENT THIN FILMS FORMED FROM NEW FLUORINATED DERIVATIVES OF 3,4-ETHYLENEDIOXYTHIOPHENE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2005-03-03 | — | — | WO | disclosed |
| US-20040214985-A1 | HIGHLY CONDUCTING AND TRANSPARENT THIN FILMS FORMED FROM NEW FLUORINATED DERIVATIVES OF 3,4-ETHYLENEDIOXYTHIOPHENE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2004-10-28 | — | — | US | disclosed |
| EP-0753002-A1 | MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS | AMGEN INC. (US) | 1997-01-15 | — | — | EP | disclosed |
| WO-1995026972-A1 | MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS | AMGEN INC. (US) | 1995-10-12 | — | — | WO | disclosed |
| WO-1993011132-A1 | METHOD OF PREPARING THE ANTIBIOTIC CEFACLOR | CIBA-GEIGY AG (CH) | 1993-06-10 | — | — | WO | disclosed |
| US-5166435-A | Hydrogenation with platinum catalyst of nitro compound in presence of nitrogen base and organophosphorus compound | AKZO N.V. (NL) | 1992-11-24 | — | — | US | disclosed |
| EP-0192003-B1 | PREPARATION OF 4-SUBSTITUTED PYRIDINES AND QUATERNARY PYRIDINE SALTS USEFUL THEREFOR | NEPERA, INC. (US) | 1989-08-02 | — | — | EP | disclosed |
| US-4772713-A | Quaternary pyridine salts useful for preparation of 4-substituted pyridines | NEPERA, INC. (US) | 1988-09-20 | — | — | US | disclosed |
| US-4672121-A | ACRYLAMIDE QUATERNIZING AGENTS, NUCLEOPHILIC DISPLACEMENT AT PARA POSITION, DEQUATERNIZATION | NEPERA CHEMICAL CO. (US) | 1987-06-09 | — | — | US | disclosed |
| US-4672121-A | ACRYLAMIDE QUATERNIZING AGENTS, NUCLEOPHILIC DISPLACEMENT AT PARA POSITION, DEQUATERNIZATION | NEPERA CHEMICAL CO. (US) | 1987-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170137468-A1 | MODULATION OF COMPLEMENT ACTIVITY | C5, C3AR1, CFH | AOC1 521/4885AOC3 650/4885KDM4C 3479/4885 |
| US-20200255390-A1 | ENTECAVIR INTERMEDIATE, SYNTHETIC METHOD THEREOF AND SYNTHETIC METHOD FOR ENTECAVIR | ENTPD5, SAMHD1, ENTPD8 | AOC1 3256/4885AOC3 4185/4885KDM4C 3726/4885 |
| US-20220151985-A1 | IMMUNOSTIMULATOR AND FOOD OR BEVERAGE FOR IMMUNOSTIMULATION | IFNG, IL2, NFATC1 | AOC1 1081/4885AOC3 3519/4885KDM4C 3495/4885 |
| US-20100266539-A1 | CHEMOKINE RECEPTOR ANTAGONIST AND MEDICAL USE THEREOF | CCR5, CCR4, CCR1 | AOC1 2456/4885AOC3 2814/4885KDM4C 4511/4885 |
| US-11046663-B2 | Entecavir intermediate, synthetic method thereof and synthetic method for entecavir | ENTPD5, SAMHD1, ENTPD8 | AOC1 3256/4885AOC3 4185/4885KDM4C 3726/4885 |
| US-20070254886-A1 | Chemokine Receptor Antagonist and Medical Use Thereof | CCR5, CCR4, CCR1 | AOC1 2456/4885AOC3 2814/4885KDM4C 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.